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ABSTRACT
Saccharomyces cerevisiae Srs2 helicase plays at
least two distinct functions. One is to prevent
recombinational repair through its recruitment
by sumoylated Proliferating Cell Nuclear Antigen
(PCNA), evidenced in postreplication-repair defi-
cient cells, and a second one is to eliminate poten-
tially lethal intermediates formed by recombination
proteins. Both actions are believed to involve the
capacity of Srs2 to displace Rad51 upon transloca-
tion on single-stranded DNA (ssDNA), though a role
of its helicase activity may be important to remove
some toxic recombination structures. Here, we
described two new mutants, srs2R1 and srs2R3,
that have lost the ability to hinder recombinational
repair in postreplication-repair mutants, but are still
able to remove toxic recombination structures.
Although the mutants present very similar pheno-
types, the mutated proteins are differently affected
in their biochemical activities. Srs2R1 has lost its
capacity to interact with sumoylated PCNA while
the biochemical activities of Srs2R3 are attenuated
(ATPase, helicase, DNA binding and ability to dis-
place Rad51 from ssDNA). In addition, crossover
(CO) frequencies are increased in both mutants.
The different roles of Srs2, in relation to its eventual
recruitment by sumoylated PCNA, are discussed.
INTRODUCTION
DNA helicases are present in all kingdoms and perform an
extraordinary variety of functions in cells. They play
important roles in DNA metabolic processes such as repli-
cation, repair, recombination and transcription. Their
DNA unwinding and translocase activities begin to be
well characterized at the biochemical and structural
levels (1). However, much remains to be understood
about their roles in vivo. Since all organisms express
multiple DNA helicases, a high degree of functional
specialization should exist. This is particularly true for
the control of homologous recombination (HR) (2). In
Saccharomyces cerevisiae, at least six diﬀerent helicases,
Sgs1, Srs2, Mph1, Mer3, Pif1 and Rrm3 are positively
or negatively involved in HR, increasing or decreasing
recombination rates. They all perform speciﬁc functions
that cannot be executed by another one. When and how
these helicases act remains unclear. Partial answers to
these questions have been recently obtained for Srs2.
Srs2 belongs to the SF1 helicase family and is structu-
rally and functionally related to the bacterial UvrD heli-
case (3,4). Mutants of SRS2 were ﬁrst described as partial
suppressors of the radiation sensitivity of rad6 and rad18
mutants (5), defective in postreplicative DNA repair
(PRR). They were later isolated as hyper-recombination
mutants (6) and as suppressors of the methyl methane-
sulfonate (MMS) sensitivity of rad18 cells (3). In RAD18
background, the single srs2 mutants are sensitive to
ultraviolet (UV) light (3), a phenotype dependent on
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unpublished data] that are all involved in the formation/
stabilization of presynaptic Rad51 nucleoﬁlaments. This
epistasis of rad51 over srs2, together with data showing
that Srs2 prevents recombinational repair in cells contain-
ing leaky alleles of RAD51 or RAD52 (7–10), led to the
proposal that Srs2 eliminates toxic recombination inter-
mediates (11) rather than preventing their formation.
This hypothesis was later supported by the ability of
Srs2 to dismantle Rad51 nucleoprotein ﬁlaments formed
in vitro on single-stranded DNA (ssDNA) through its
translocase activity (12,13). In the absence of any treat-
ment, toxic recombination intermediates are also formed
in double mutants involving srs2 and mutations aﬀect-
ing recombination and/or replication such as rad54 and
sgs1. The synthetic lethality or sickness of the double
mutants is suppressed by a third mutation in RAD51,
RAD52, RAD55 or RAD57 (10,14,15)). Recently, it was
proposed that not only the translocase but also the heli-
case activity of Srs2 may reverse nonproductive recombi-
nation intermediates resulting from strand invasion of the
homologous duplex DNA (16).
While the deletion of SRS2 sensitizes wild-type cells to
UV, it increases the resistance of the highly UV sensitive
rad6 and rad18 mutants. In these PRR-deﬁcient contexts, it
has been demonstrated that the high sensitivities of rad6
and rad18 cells is related to the prevention of recombina-
tional repair by Srs2 which is recruited by a sumoylated
form of PCNA (17,18). Indeed, deletion of the Small
Ubiquitin-related Modiﬁer (SUMO)-speciﬁc ligase gene
SIZ1, which is responsible for the sumoylation of PCNA
on the K164 lysine or PCNA mutations that prevent its
sumoylation suppress DNA damage sensitivities of rad18
or rad6 cells, as does the deletion of SRS2 (17–19).
Srs2 was also shown to be involved in crossover (CO)
control and proposed to unwind the invading strand of
recombination intermediates, allowing conversion but pre-
venting formation of COs (20,21). This role of Srs2 would
involve the helicase activity, and appears to be dependent
on PCNA sumoylation (21).
These genetic data show that Srs2 plays diﬀerent roles.
One is to eliminate toxic recombination intermediates.
Importantly, in wild-type cells, a SIZ1 deletion has no
signiﬁcant eﬀect on repair, mutagenesis or recombination
(18,19), suggesting that elimination of toxic intermediates
does not depend on PCNA sumoylation. Another role of
Srs2 is to prevent recombinational repair. This has been
evidenced only in PRR-deﬁcient contexts, and the extra-
polation of this activity to wild-type cells remains ques-
tionable in view of the absence of eﬀects of the single siz1
mutation.
In a hope to obtain mutations that separate the func-
tions, we screened for new Srs2 mutations suppressing the
MMS sensitivity of rad18 cells. We describe here two of
them which confer UV resistance to rad18 cells but are not
by themselves UV or MMS sensitive. However, they do
have an eﬀect on the incidence of reciprocal recombina-
tion associated to gene conversion events. The biochem-
ical study of the puriﬁed mutant proteins indicates that the
mutations aﬀect diﬀerently the activities of Srs2, although
their biological eﬀects are very similar.
MATERIALS AND METHODS
Yeaststrains and genetic analysis
Except for CO experiments, the strain used in this study are
isogenic derivatives of either FF1852 (MATa leu2-3,112
trp1-289 ura3-52 ade5) or of FF18733 (MATa leu2-3,112
trp1-289 ura3-52 his7-2 lys1-1). The MATa haploids in the
FF1852 series are: FF1886, rad18::LEU2 srs2R1; FF1888,
rad18::LEU2 srs2R3; FF18672, srs2::LEU2; D84-3B,
siz1::KAN; D48-3C, srs2R1; D52-2C, srs2R3; the MATa
in the same background is FF18238, rad18::LEU2. The
MATa haploids in the FF18733 series are FF182029,
pol30-K127R; FF182031, pol30-K127/164R; FF182027,
pol30-K164R; D83-5B, rad18::KAN srs2::KAN. In the
same background, the MATa strains are FF181496,
sgs1::URA3; FF18974, rad54::LEU2.
For CO experiments, the strains used are derivatives of
W303, as were the strains used in our previous experi-
ments on COs (21). The wild-type SRS2 and the mutants
srs2R1 and srs2R3 are tagged by HA. We found no eﬀect
of the HA tag on the resistance to genotoxic agents, indi-
cating that the Srs2 proteins are functional. The ‘CY2715’
wild-type HA-SRS2 strain (22) was a gift of Dr Foiani.
HA-SRS2 was replaced by HA-srs2R1 or srs2R3 by the
pop-in/pop-out method. For this, srs2R1 and srs2R3 were
cloned into the URA3 pRS406 vector. The linearized plas-
mids were integrated into the HA-SRS2 strain, and pop-
out events were selected on 5-ﬂuoroorotic acid (5FOA), a
drug that allows only the growth of Ura
  cells (23). The
presence of the srs2R1 or srs2R3 mutation was tested by
the suppression of rad18 MMS sensitivity in meiotic
analysis of diploids obtained by crossing the strains with
rad18 haploids. It was conﬁrmed by DNA sequencing.
The strains were crossed with the srs2D haploid bearing
the ectopic recombination system (D498-1C) to isolate
from the meiotic progeny the wild-type strain ‘D508-
10C’ of genotype MATa arg4-Bg URA3::arg4-RV::ura3-
1 ade2-1 trp1-1 leu2-3,112 his3-11,15 can1-100
HA3SRS2::srs2. The corresponding HA-srs2R1 and HA-
srs2R3 strains are ‘D511-4D’ and ‘D509-8B’, respectively.
Genetic analyses were performed according to published
procedures (24).
Determination of CO frequencies
This analysis was performed as previously described (21).
Brieﬂy, CO frequencies associated to gene conversion
events were determined in haploid cells carrying two
arg4 alleles mutated at diﬀerent sites and located on dif-
ferent chromosomes. One allele is at its endogenous loca-
tion on chromosome VIII, and the other one is located on
chromosome V, between a wild-type and a mutated allele
of URA3 in direct orientations. When gene conversion
occurs without CO, the two URA3 and ura3-1 genes
remain in the parental direct repeat conﬁguration in
which loss of URA3 is a frequent event. A CO associated
to a conversion of an arg4 allele generates a reciprocal
translocation and a separation of the URA3 and ura3-1
alleles on each of the translocated chromosomes. In this
situation, loss of the URA3 information is much less fre-
quent. Spontaneous and independent Arg
+ convertants
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the same medium. To determine the relative frequencies of
URA3 losses, the plates are replicated on a medium con-
taining 5-FOA, a drug that allows only the growth of
Ura
  cells (23). Patches that give rise to numerous Ura
 
papillae derive from a conversion without CO and patches
with no or a very few Ura
  papillae reveal a CO event.
This was veriﬁed by molecular analyses on a sample of
convertants (21).
UV treatment
Stationary phase (RAD18 background) or exponentially
growing (rad18 context) cells were washed in sterile
water and resuspended at appropriate dilutions. UV irra-
diation (254nm) was applied after plating on YPD and
survival was determined after 3 days of incubation at
308C. For spot assays, exponentially growing cells were
resuspended in water at 3.10
6 cells/ml and 7ml of 10-fold
serial dilutions were spotted onto plates lacking leucine to
select for cells that retained the plasmid. The control and
UV-irradiated plates were incubated as described above.
Plasmids andproteins
In order to clone the mutant genes into baculoviruses, we
ﬁrst constructed the p14HB-srs2R1 and p14HB-srs2R3
plasmids by the gap repair method (25). The centromeric
replicative p14HB plasmid contains the whole wild-type
SRS2 coding sequence and, upstream of the ORF, a
BamHI site which was introduced by site-directed muta-
genesis in p14H (3). A gap was made in the region of either
the srs2R1 or srs2R3, and the gapped plasmids were intro-
duced into the corresponding mutant cells. For srs2R1,
BbvCI-gapped p14HB (13) was introduced in FF1886
and the repaired plasmid was recovered. For srs2R3, the
same procedure was followed using XbaI-gapped p14HB
introduced into FF1888. The BamHI-EcoRI fragment of
p14HB-srs2R1 or p14HB-srs2R3 was cloned into
pBacPAK-His1. The recombinant baculoviruses were
constructed as recommended by the manufacturer
(Invitrogen, Cergy Pontoise, France). It encodes the Srs2
proteins with 17 additional amino acid residues
(MGHHHHHHVVDKLGSQM) fused to its N-terminal
methionine. The wild-type fusion protein was found to
complement the genotoxic sensitivity of srs2 cells (data
not shown). Srs2 wild-type and mutant proteins were pro-
duced and puriﬁed as described previously (13).
To overproduce Srs2 wild-type and mutant proteins in
yeast, the HindIII-SphI fragment of p14HB vectors was
cloned into the multicopy plasmid YEp13 (26). To elim-
inate the BamH1 site and restore the genuine sequence, the
EagI-Bsu36I fragment that contains the BamH1 site was
replaced by the corresponding fragment of p14H.
The K41A mutation in the Walker A site in Srs2 was
introduced by using mutagenic DNA primers and
QuikChange site-directed mutagenesis kit (Stratagene,
Massy, France).
ATPase assay
ATPase activity was measured by linking ATP hydrolysis
to the oxidation of NADH as described previously (27).
The dependence of the ATPase reaction on ssDNA cofac-
tor (a 56 mer) was examined by the above method at 378C
in a buﬀer containing 50mM Tris–HCl pH7.6, 100mM
NaCl, 7mM MgCl2, 5mM DTT, 80mgml
 1 BSA and
1mM ATP. Values for the Michaelis-Menten constants
kcat and Km for ATP at saturating amount of ssDNA
were derived by ﬁtting data directly to the Michaelis-
Menten equation.
Helicase assay
A forked DNA built by the annealing of two oligonucleo-
tides, P1 (50-AGAAGGTTTCGAATCAGAGGTAGGT
GCCCGGCCTCCAACTTGCCGTATTCCTGGT) and
Cy5-50-labeled P2 (50-Cy5-ACCAGGAATACGGCAA
GTTGGAGGCCGGGCTGGATGGAGACTAAGCTT
TGGAAGT) was used to assay the helicase activity
of Srs2. DNA substrate (20fmol) was incubated at 258C
with 62nM Srs2 in buﬀer A (50mM Tris–HCl pH 7.6,
7mM MgCl2, 5mM DTT, 2mM ATP and 25mgml
 1
BSA). Reactions were stopped by addition of 150mM
EDTA. The reaction products were resolved by electro-
phoresis on a 8% nondenaturating polyacrylamide gel in
Tris-borate-EDTA (TBE) buﬀer and quantiﬁed by
ImageQuant software.
Electrophoretic mobility shiftassay
The same forked DNA (20fmol) used in helicase assay
was incubated with increasing amount of Srs2 protein
in buﬀer A without ATP for 30min at 258C. Gel shift
was detected after electrophoresis on a 6% nondenaturat-
ing polyacrylamide gel using a Storm 960 apparatus
(GE Healthcare Biosciences, Saclay, France).
Electron microscopy (EM)
Rad51 ﬁlaments on ssDNA were formed by incubation at
378C of 3.5mM Rad51 protein in 42mM MOPS pH 7.2,
3mM Mg(OAc)2, 1mM DTT, 20mM NaCl, 2.5mM ATP
with 11mM (ntd) X174 viral (+) strand for 3min fol-
lowed by addition of 330 nM RPA and subsequent incu-
bation for 15min. Five microliters of this reaction was
mixed with 5ml of various amount of Srs2 diluted in
20mM phosphate buﬀer pH 7.8, 200mM NaCl, 10% gly-
cerol and 1mM ß-mercaptoethanol and incubated for
10min at 378C. The reaction mixtures were then diluted
20-fold in 10mM Tris–HCl pH 7.5, 50mM NaCl, 5mM
MgCl2 without any chemical ﬁxation and analyzed by EM
as previously described (28).
Immunoprecipitation
For immunoprecipitation assays, yeast native extracts
from FF182029 treated with 0.3% MMS were prepared
as described previously (18). Extract (2.5mg of protein)
was incubated overnight in buﬀer B (50mM Tris–HCl pH
7.4, 150mM NaCl and supplemented with protease inhib-
itors) at 48C with 1.7mg of puriﬁed
HisSrs2,
HisSrs2R1
or
HisSrs2R3 protein and 1mg of antibody against His-
tag (Roche Diagnostics, Meylan, France). Prewashed
protein G agarose beads (Roche Diagnostics) were then
introduced for 5hrs at 48C. Beads were washed six times
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loading buﬀer. Srs2 and PCNA were detected by
Western blotting using polyclonal anti-Srs2 antibody
(sc-11991, Santa Cruz Biotechnology, Heidelberg,
Germany), and a polyclonal rabbit anti-PCNA serum
(a generous gift from Martine Heude).
RESULTS
Isolation of srs2 mutationsthat partially suppress the
UV sensitivity of rad18Dmutantbut do notconfer UV
sensitivity in otherwise wild-type cells
In a search for new suppressors of the sensitivity to the
alkylating agent MMS of rad18 cells, we isolated several
srs2 mutants, which fell into two groups. Mutations
belonging to the ﬁrst one have the same eﬀects as srs2:
they partially suppress the MMS and UV sensitivities of
rad18 cells, and in the RAD18 context, the mutants are
UV sensitive and show increased rates of spontaneous and
UV-induced intragenic recombination. The mutations of
the second group also partially suppress the sensitivities to
genotoxic agents of rad18 cells but they do not confer
UV sensitivity in the RAD18 context. We focused our
attention on two mutants of this last class, srs2R1 and
srs2R3. Figure 1A shows that they both suppress the
UV sensitivity of rad18 cells, as eﬃciently as does
srs2. However, unlike srs2 cells, the single srs2R1
and srs2R3 mutants are not UV sensitive (Figure 1B).
The suppression of UV sensitivity in rad18 cells is not
due to a down regulation of the mutated proteins, as
judged by western blot analysis (Figure 1C). As reminded
in the introduction, the UV sensitivity of srs2 cells is
believed to be due to the binding of recombination pro-
teins to ssDNA, before and/or during replication, gener-
ating toxic DNA structures if not processed by Srs2. That
srs2R1 and srs2R3 are not UV sensitive suggests that these
two mutated proteins are still able to remove the toxic
recombination intermediates induced by UV treatment.
srs2R1and srs2R3 mutationsdo notshow anegative
interaction whencombined witheither rad54"or sgs1"
Toxic recombination intermediates are also formed in dif-
ferent double mutants involving srs2, notably srs2
rad54 cells, which are dead, and srs2 sgs1, which
are extremely sick. We asked whether srs2R1 or srs2R3
aﬀect the viability of rad54 and sgs1 mutants, as does
srs2. We performed tetrad analysis on diploids heterozy-
gous for srs2R1 and rad54 or sgs1, and srs2R3 and
rad54 or sgs1. In these diploids, rad18 was
also heterozygous but this mutation has no eﬀect on the
viability of their meiotic progeny. While the negative inter-
action between srs2 and rad54 or sgs1 were once
more evidenced, no interaction was observed between
srs2R1 or srs2R3 andrad54or sgs1: the double mutants
rad54 srs2R1, rad54 srs2R3, sgs1 srs2R1 and sgs1
srs2R3 are viable and have no growth defects, as judged by
the size of the colonies (Figure 2). Thus, Srs2R1 and
Srs2R3 proteins have retained the capacity to disrupt
toxic recombination structures formed not only after UV
irradiation but also in the absence of Rad54 or Sgs1.
Molecular characterization ofsrs2R1 andsrs2R3 mutations
The nature of srs2R1 and srs2R3 mutations was deter-
mined by DNA sequencing after PCR ampliﬁcation
of the entire genes (Figure 3). srs2R3 has a G to
T transversion leading to the substitution of the arginine
Figure 1. UV survival of srs2R1 and srs2R3 mutants. (A) Like srs2,
srs2R1 and srs2R3 mutations partially suppress the UV sensitivity of
rad18D cells. (B) srs2R1 and srs2R3 mutants are as resistant as SRS2
cells to UV, while srs2 cells are sensitive after irradiation. (C) Western
blot analysis indicates that Srs2R1 and Srs2R3 are present in the same
amount as Srs2 in rad18 cells.
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helicase domain IV (amino acid 310 to 321). srs2R1 muta-
tion is the addition of one adenine in position 3480. The
resulting protein is shorter by six amino acids and ﬁve of
the last six amino acids of the C-terminal end are changed.
This modiﬁcation occurs in the interacting domain with
sumoylated PCNA (18).
Unexpectedly, although the srs2R1 and srs2R3 muta-
tions were located in a diﬀerent region of the gene, the
mutants have similar phenotypes. In order to determine
the defective properties of these mutants, we puriﬁed the
mutated proteins and compared their biochemical proper-
ties to those of the wild-type protein.
UnlikeSrs2R1, Srs2R3is affected forall ofits biochemical
functions
Srs2 is a ssDNA-dependent ATPase (12,13,29). The ATP
hydrolysis is believed to reﬂect its translocase activity
on ssDNA. Therefore, we determined the kcat and the
Km for ATP of the wild-type and the two mutated Srs2
proteins, using a 56-mer oligonucleotide as ssDNA
cofactor (Table 1). The ATPase activity was determined
with saturating amounts of ssDNA (data not shown) and,
therefore, represents the true catalytic activity once the
protein is bound to the ssDNA. Srs2R1 binds and hydro-
lyzes ATP as eﬃciently as Srs2 (Km 94mM versus 143mM
and kcat 2778min
 1 versus 3316min
 1). These kcat values
are in the same range that the one previously reported
measured with X viral (+) strand as cofactor (29).
Unlike Srs2R1, Srs2R3 is strongly aﬀected for ATP
hydrolysis, with only about 10% of the wild-type activity
(kcat 373min
 1 versus 3316min
 1). Surprisingly, Srs2R3
binds more eﬃciently ATP than the wild-type protein (Km
19mM versus 143mM). However, the ATP intracellular
concentration in yeast is supposed to be superior than
1mM (30), a much higher value than the calculated Km
of Srs2 for ATP. It indicates that the ATP binding para-
meter can be disregarded for the in vivo function.
We next studied the DNA helicase activities of the two
Srs2 mutant proteins, using a 50-Cy5-labeled forked DNA
containing a 30-bp duplex region ﬂanked by two single-
stranded tails of 25 nucleotides. As shown in Figure 4A
and B, the wild-type Srs2 and the mutated Srs2R1 proteins
have a similar helicase activity, while Srs2R3 unwinds
poorly the DNA substrate. The attenuated helicase ability
of Srs2R3 may result from an ATPase defect and/or from
a default in DNA binding. For this reason, we compared
the DNA binding abilities of Srs2R3 and of the wild-type
protein with a DNA mobility shift assay. We incubated
increasing amounts of wild-type Srs2 and Srs2R3 with
the same DNA substrate used in the helicase assay fol-
lowed by resolution of the reaction mixtures in nondena-
turating polyacrylamide gels. As shown in Figure 4C,
Srs2R3 binds less eﬃciently forked DNA than wild-type
Srs2. At 140nM protein, almost all DNA was bound
to Srs2 while <50% of it was bound by Srs2R3.
Srs2R3, butnotSrs2R1, disrupts less efficiently the Rad51
presynaptic filament
Srs2 is able to disrupt Rad51 presynaptic ﬁlaments
(12,13). Because srs2R1 and srs2R3 mutants are not UV
sensitive (Figure 1), we hypothesized that Srs2R1 and
Srs2R3 remove toxic recombination intermediates by
releasing Rad51 from the nucleoprotein ﬁlament. EM
was used to monitor this activity for both mutated and
wild-type proteins. Rad51 was ﬁrst incubated for 3min
with X174 ssDNA followed by addition of RPA and
subsequent incubation for another 15min in order to
assemble Rad51 nucleoprotein ﬁlaments. As a function
Figure 2. srs2R1 and srs2R3 do not aﬀect the viability of rad54 or
sgs1 cells. Two tetrads from crosses indicated above each picture are
shown. Circles and squares indicate the rad54 srs2 and sgs1 srs2
combinations, respectively. (A) While rad54 srs2 cells are dead,
rad54 srs2R1 and rad54 srs2R3 double mutants are perfectly
viable. (B) The severe growth defect seen in sgs1 srs2 cells is not
observed in either sgs1 srs2R1 or sgs1 srs2R3 double mutants.
Figure 3. (A) Localization of srs2R1 and srs2R3 mutations. (B) Modiﬁ-
cations induced by mutations srs2R1 and srs2R3 at the protein level.
Table 1. Km and kcat values of the enzymes for ATP
Protein Km (mM) kcat (min
 1)
Srs2 143 3316
Srs2R1 94 2278
Srs2R3 19 373
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progressive loss of Rad51 ﬁlaments, coupled with a con-
comitant formation of RPA-ssDNA complexes, was
observed (Figure 5). At 120nM Srs2 or Srs2R1, almost
all the observed DNA molecules were covered by RPA
while, at the same concentration, <5% of the Rad51
nucleoprotein ﬁlaments were destabilized by Srs2R3.
400nM of Srs2 were required to obtain disruption of all
Rad51 ﬁlaments. Because disassembly of the presynaptic
ﬁlament requires the translocase activity of Srs2 on
ssDNA, a function that requires ATP hydrolysis, the
weak capacity of Srs2R3 protein to remove Rad51 from
ssDNA may result from two failing activities: a reduced
ability to bind ssDNA and/or a weak ATPase activity.
Taken together, the results from biochemical and EM
analyses clearly indicate an attenuated activity for all the
tested functions of Srs2R3, while Srs2R1 behaves like the
wild-type Srs2 protein.
Srs2R1 doesnot bindSUMO-modified PCNA
It was previously reported that Srs2 preferentially inter-
acts with the sumoylated forms of PCNA (17,18). This
interaction involves the C-terminal 138 residues of Srs2
protein, but a C-terminal truncation of the last six
amino acids strongly reduces the two-hybrid interaction
with both SUMO and PCNA.
The Srs2R1 is modiﬁed in its C-terminal domain. The
protein lost its six last residues and 5 of the six last amino
acids are changed (Figure 3). Therefore, we asked if the
ability of Srs2R1 to interact with sumoylated PCNA is
aﬀected. Puriﬁed His-tagged Srs2 wild-type or mutated
proteins were incubated with total cell extracts in order
to examine their binding to PCNA and sumoylated
PCNA. Extracts were prepared from a pol30-K127R
mutant treated with 0.3% MMS before lysis to induce
extensive SUMO conjugation at lysine 164 (K164) (31).
The pol30-K127R mutant was used because this lysine
was shown to be sumoylated to a small extent in a Siz1-
independent manner, a modiﬁcation that plays a minor
biological role (17,18). Under these conditions, the
HisSrs2 and
HisSrs2R3 recombinant proteins clearly
bound the K164-sumoylated PCNA while no interaction
could be detected with the
HisSrs2R1 recombinant protein
(Figure 6). Interestingly, we detected a very faint interac-
tion between unmodiﬁed PCNA and Srs2 and no interac-
tion between unmodiﬁed PCNA and either Srs2R1 or
Srs2R3, even with longer exposure of the blot (data not
shown). These data diﬀer from results found previously in
Figure 4. Srs2R3 is defective in both helicase activity and DNA binding. (A) Kinetics of helicase activity of wild-type and mutated Srs2. (B)
Quantiﬁcation of experiments showed in (A). Each point represents the average of three independent assays. Error bars show the standard deviation.
(C) Srs2R3 binds forked DNA less eﬃciently than Srs2 as observed by gel shift assay.
Nucleic Acids Research, 2008, Vol. 36, No. 15 4969two independent studies (17,18) showing an important
interaction of Srs2 with non-sumoylated PCNA. The
reason for this discrepancy is not clear, it could reﬂect
small diﬀerences in experimental procedures. However,
as we will show below, the interaction between Srs2 and
unmodiﬁed PCNA does not seem to play a role in vivo.
Overexpression of Srs2R1and Srs2R3 sensitizes rad18D
srs2Dbutnot pol30-K127/164R cells to UVradiation
Although the Srs2R3 protein still interacts with K164-
sumoylated PCNA, the mutation suppresses the UV sen-
sitivity of rad18 cells to the same extent as does the
deletion of SRS2 (Figure 1A). Since the diﬀerent activities
of Srs2 tested are present but less eﬃcient in srs2R3,w e
predicted that overexpressing the mutant protein would
sensitize the double mutant rad18 srs2 cells. To test
this idea, we introduced SRS2 or srs2R3 under their
own promoter into the multicopy yeast vector YEp13.
The rad18 srs2 double mutant cells were transformed
and UV survival assays performed. As predicted, overex-
pression of srs2R3 strongly reduces UV survival of these
cells, and furthermore, to a similar extent as does the wild-
type SRS2 overexpression (Figure 7A). In the same con-
ditions, overexpression of the Srs2K41A helicase- and
ATPase-dead mutant protein (32) has no eﬀect
(Figure 7A), indicating that indeed the srs2R3 overexpres-
sion eﬀect relates to an increased activity and not simply
to the abnormally high protein concentration. These
results support the view that a single copy of srs2R3
does not produce enough protein to prevent recombina-
tional repair in UV-treated rad18 cells, and consequently
that the Srs2R3 protein suﬀers from a decreased speciﬁc
activity rather than from a complete deﬁciency in a
particular activity.
When we did the same experiment with srs2R1, we also
observed that its overexpression sensitizes rad18 srs2
cells (Figure 7A). One possible explanation for this result
is that a residual interaction (although not detected in our
experiments) between the overproduced Srs2R1 proteins
and K164-sumoylated PCNA allows enough helicase
recruitment to prevent recombinational repair. A second
explanation is that overproduction of Srs2 prevents
recombinational repair by a recruitment through unmodi-
ﬁed PCNA or directly through its interaction with Rad51
(12). In order to diﬀerentiate between these possibilities,
srs2R1 was overexpressed in the pol30-K127/164R mutant
unable to be sumoylated on lysine 127 or sumoylated or
ubiquitinated on lysine 164. Overproduction of Srs2R1
does not sensitize the pol30-K127/164R mutant to UV
(Figure 7B). Similar results are obtained when wild-type
SRS2 or srs2R3 were overexpressed. Altogether, these
data indicate that, at least in a context where PCNA
cannot be ubiquitinated, the recruitment of Srs2 to pre-
vent recombinational repair is strictly dependent upon its
interaction with sumoylated PCNA.
Srs2R1 and Srs2R3 mutants showincreased CO frequencies
The absence of Srs2 was shown to enhance both
DSB-induced and spontaneous CO frequencies (20,21).
Figure 5. Srs2R3 disrupts the Rad51 presynaptic ﬁlament less eﬃciently
than Srs2 and Srs2R1. (A) Rad51-ssDNA nucleoprotein ﬁlament. (B)
Preformed Rad51-ssDNA complexes were incubated for 10min with
Srs2. The arrows point to the ssDNA covered with RPA. (C) Blow-
up of ssDNA covered with RPA. (D) The percentage of disrupted
Rad51 presynaptic ﬁlament was determined for various amounts of
helicases. For each concentration, 300–500 molecules were counted.
Scale bars, 50nm.
Figure 6. Srs2R1 does not interact with sumoylated PCNA.
Immunoprecipitation experiments were performed with total cell lysates
prepared from pol30-K127R mutant treated with 0.3% MMS to gen-
erate maximal levels of SUMO-modiﬁed PCNA. Input and bound frac-
tions were analyzed by western blot as indicated.
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recombination intermediates at a postsynaptic stage. It
unwinds the invading and elongated strand from its tem-
plate, promoting synthesis-dependent strand annealing
(SDSA), a mechanism that allows gene conversion but
not associated COs. A partially unanswered question con-
cerns the recruitment of Srs2 to the D-loop. Using a
genetic system allowing to determine the frequency of
COs associated to a selectable conversion event involving
ectopic heteroalleles (see Materials and methods section),
we previously showed (21) that CO frequencies rise from
11% in wild-type cells to 50% in both the srs2 mutant
and in the pol30-K127/164R mutant that can neither be
sumoylated nor ubiquitinated at the lysine 164 of PCNA
(31). This result strongly suggested that SUMO-modiﬁed
PCNA recruits Srs2 into the D-loop. However, because
the double PCNA mutant is also deﬁcient in PRR, the
high incidence of COs observed in this strain is possibly
also due to the PRR deﬁciency, and not only to the lack
of Srs2 recruitment by PCNA. To address this question,
we used the srs2R1 mutation, which prevents the interac-
tion of the helicase with PCNA. We introduced at their
native locus a HA-tagged version of SRS2 or of srs2R1
into the strain used by Robert et al. (21). The percentage
of COs associated with spontaneous gene conversion
events was found to be increased 1.8-fold in srs2R1
as compared with SRS2 cells (25 and 14%, respectively)
(Figure 8). This result shows that the interaction between
SUMO-modiﬁed PCNA and Srs2 is indeed involved in
CO control. However, the level of COs measured in
srs2R1 (25%) is half that in srs2 or in the double
PCNA mutants (50%). It suggests that Srs2 controls CO
both in a PCNA-dependent and independent fashion.
We cannot formally exclude that a possible residual inter-
action between PCNA and Srs2R1 could account for
this result. The same experiment was carried out with
srs2R3. Interestingly, this mutant leads to a 2.3-fold
increase in COs over the wild-type level (33 and 14%,
respectively). The percentage is still lower than that
observed in srs2 mutants. The eﬀect of this mutation
likely results from the decreased helicase activity of
Srs2R3, and thus from less eﬃcient repair through the
SDSA pathway.
DISCUSSION
Early studies on srs2 mutations revealed two opposite
eﬀects with respect to radiations. In the highly sensitive
rad6 or rad18 haploid mutants, deﬁcient for PRR, srs2
Figure 7. Overexpression of Srs2R1 and Srs2R3 sensitizes rad18 srs2 cells (A) but not pol30-K127/164R cells (B) to UV radiation. Ten-fold serial
dilutions of an equal number of exponentially phase growing cells were spotted onto plates and irradiated with ultraviolet light at indicated doses.
Figure 8. CO bias observed in srs2 mutants. The percentage of CO
was determined using three individual segregants for each genotype.
Nucleic Acids Research, 2008, Vol. 36, No. 15 4971suppresses the sensitivity of a subpopulation of cells (5),
while in PRR-proﬁcient cells, it sensitizes a subpopulation
of cells (3). It is now understood that these eﬀects reﬂect
two roles of Srs2. One is the elimination of potentially
toxic structures formed by recombination proteins (11),
and a second role is the prevention of recombinational
repair through its recruitment by sumoylated PCNA, evi-
denced only in PRR-deﬁcient cells (17,18). The ability of
Srs2 to disrupt in vitro Rad51 nucleoﬁlaments on ssDNA
would be suﬃcient to account for the elimination of both
the toxic and the recombination intermediates. It is likely
that toxic structures are also formed after UV treatment of
rad18 srs2 cells, but this cannot be directly tested because
rad51, as well as other mutants aﬀected in the formation
of Rad51 nucleoﬁlaments, has a synergistic eﬀect with
rad18 on UV survival, regardless of the status of Srs2.
In this study we describe two new srs2 mutants that
have acquired the ability to perform recombinational
repair in a rad18 context, but have retained the ability to
reverse toxic structures in a RAD18 context. The biochem-
ical activities of the two mutant proteins are diﬀerently
aﬀected. The only known defect of Srs2R1 is the loss of
interaction with sumoylated PCNA. This explains its sup-
pressive eﬀect on the UV sensitivity of rad18 cells. The
mutation is located in the C-terminal domain of the pro-
tein, known to interact with sumoylated PCNA, and dele-
tions in this domain were reported to suppress the
sensitivity of PRR mutants (18). Diﬀerently, Srs2R3 inter-
acts as eﬃciently as the wild-type protein with sumoylated
PCNA and its cellular amount in the cells is not decreased.
However, the ATPase and helicase activities of the pro-
tein, as well as its ability to disrupt Rad51 nucleoprotein
ﬁlaments, are decreased. We suggest that the inability of
Srs2R3 to prevent recombinational repair in rad18 cells
may be related to the size of the Rad51 presynaptic ﬁla-
ment that must be removed. Indeed, EM analyses revealed
that UV lesions, if not repaired, induce uncoupling of
nascent strands synthesis at replication forks leading to
up to 3kb long ssDNA regions (33). In rad18 cells, only
recombination could save the cells, but Srs2 counteracts
this repair. Because of its weak translocase activity,
Srs2R3 would be unable to fully destroy the Rad51
nucleoﬁlaments, allowing recombinational repair to
occur. This interpretation ﬁts with our data showing
that overexpression of Srs2R3 in rad18 srs2 cells
largely sensitizes the cells. It ﬁts also with the semi dom-
inance of srs2 mutants in rad18 homozygous diploids: the
cells are more sensitive with two copies of SRS2 than with
a single one, indicating a gene dosage eﬀect (34).
Removal oftoxic recombination structures by Srs2
doesnot requirean interaction withsumoylated PCNA
Contrarily to srs2 cells, the two mutants srs2R1 and
srs2R3 are not UV sensitive. This indicates that the two
mutated proteins have retained the ability to reverse toxic
recombination structures. The Srs2R3 protein is therefore
in suﬃcient amount to perform this activity. It suggests
that in PRR proﬁcient cells, these structures are limited in
size and/or number. The only deﬁcient activity that we
observed for Srs2R1 is its binding to sumoylated PCNA.
This interaction is therefore not required to remove the
dead-end structures. In agreement with this conclusion,
the single siz1 mutant, deﬁcient in sumoylation of the
lysine 164 of PCNA, shows no UV sensitivity (18). We
asked if the potentially toxic intermediates formed in the
rad54 or sgs1 mutants, and revealed by their Rad51-
dependent synthetic lethality with srs2, depends on
PCNA sumoylation. The srs2R1 mutation has no eﬀect
on the growth of rad54 or sgs1 cells. Thus, the toxic struc-
tures formed in these mutants, as those formed after UV
treatment, are reversed by Srs2 independently of an inter-
action with sumoylated PCNA. In these cases, the recruit-
ment of Srs2 could be mediated through its interaction
with Rad51 (12).
Control of COsinvolves thehelicase activity ofSrs2
and ispartially dependent ofits interaction with
sumoylated PCNA
It has been proposed that Srs2 prevents COs by promoting
SDSA, a recombination pathway non-associated with
COs (20,21). This would imply the unwinding activity of
Srs2 in order to displace the elongated invading strand
from the D-loop. We recently showed that Srs2 has the
biochemical activities that are required to perform SDSA
(16). However, in vivo evidence for an implication of the
helicase function of Srs2 in this process is missing. We
hypothesized that the srs2R3 mutation which decreases
the helicase activity of Srs2 would increase the percentage
of CO associated to conversion events. We indeed found
that in this mutant CO frequency is increased from 14%
in wild-type cells to 33%, while it reaches 50% in the
absence of Srs2.
The approximate correlation between the level of COs
and that of the helicase activity supports the idea that Srs2
controls the level of COs through its helicase activity.
However, we cannot exclude the possibility that the
increased CO frequency observed in srs2R3 cells relates
to its decreased DNA binding ability and translocase
activity. An srs2 mutant aﬀected speciﬁcally in its unwind-
ing activity would be required to answer this question.
The Srs2R1 mutation increases the frequency of COs
associated with conversions from 14% in wild-type cells
to 25%. This indicates that the interaction with sumoy-
lated PCNA is involved in CO control. However, since the
percentage of COs in srs2R1 mutant is half that in srs2D
cells, it suggests that the enrollment of the Srs2 helicase
to disrupt D-loops is only partially dependent on sumoy-
lated PCNA.
It is important to note that the eﬀect on CO incidence of
srs2R1 and of srs2R3 is the only phenotype of these
mutants in a RAD18 context. In both cases, it is likely
due to a decreased eﬃciency in the processing of recombi-
nation intermediates into the SDSA pathway. This would
be related to a limited Srs2 helicase activity, for diﬀerent
reasons in each of the mutants.
What istherole ofPCNA sumoylation?
The absence of genetic eﬀects of the single siz1 or srs2R1
mutation raises the question of the role of PCNA sumoy-
lation at K164 in wild-type cells. Our favorite model is the
4972 Nucleic Acids Research, 2008, Vol. 36, No. 15following one. Since PCNA is sumoylated even in the
absence of any treatment during S phase (31) and since
the same lysine is the ubiquitin target of Rad18/Rad6, it is
reasonable to believe that the sumoylated PCNA drives
replication and avoids unintended mutation and recombi-
nation events to take place. On one hand, sumoylation of
PCNA on the lysine 164 would protect against unneces-
sary ubiquitination and, consequently, hinder the error-
prone and error-free Rad18-dependent pathways from
acting. Notably, it would prevent a recruitment of
an error prone polymerase that could introduce untar-
geted mutations. On the other hand, the sumoylated
PCNA would recruit Srs2 that counteracts recombina-
tional repair.
When the replicative polymerase encounters a blocking
lesion, a single-stranded region upstream of the synthesis
block is formed, due to the uncoupling of the two nascent
strands synthesis upon fork progression (33).
Desumoylation of PCNA through a speciﬁc isopeptidase
would occur, or new unmodiﬁed PCNA monomers would
replace the sumoylated PCNA trimers. The absence of
sumoylated PCNA opens two nonexclusive possibilities:
ubiquitination of PCNA and formation of aRad51 nucleo-
protein ﬁlament on the ssDNA region. Fork restoration
could then be mediated through the Rad18 pathways or
by recombination. It is important to note that the choice of
one or the other pathway is likely not determined by the
ubiquitination state of PCNA: it is known that recombina-
tional repair plays an important role in cells unable to
ubiquitinate PCNA (e.g. rad18 or more evidently rad18
srs2 mutants) and in cells where PCNA is presumably
ubiquitinated (e.g. rev3 or rad5 cells). Therefore, a possibil-
ity is that both PCNA ubiquitination and formation of a
Rad51 nucleoprotein ﬁlament occur concomitantly. If fork
restoration occurs by translesion synthesis, the Rad51
nucleoprotein ﬁlament might be eliminated upon progres-
sion of the polymerase.
In this scheme where PCNA is ubiquitinated upon repli-
cation arrest, the single siz1 mutation is not expected to
have any eﬀects on survival to genotoxic treatments, nor
on induced mutation or recombination frequencies. The
only siz1 eﬀects that may be predicted in otherwise wild-
type cells is an increase of untargeted mutations or recom-
bination events, due to inadvertent switch of polymerases
or/and Rad51 binding. However, these eﬀects could be too
small to overcome the other sources of spontaneous muta-
tion or recombination and to be easily detectable.
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